Home/MannKind/James O. Robbins

JO

James O. Robbins

Chairman of the Board

Therapeutic Areas

Cardiometabolic Diseases Orphan Lung Diseases

MannKind Pipeline

Drug	Indication	Phase
Afrezza	Type 1 Diabetes (Pediatric, Newly Diagnosed)	Phase 4
FUROSCIX ReadyFlow Autoinjector	Fluid Overload	Development
Technosphere Platform (New Formulations)	Undisclosed	Discovery/Preclinical

Leadership Team at MannKind

Michael Castagna

Chief Executive Officer

Chief Financial Officer

Steven B. Binder

President & Chief Operating Officer

Chief Scientific Officer

Christine Ocampo

Chief Accounting Officer

View full MannKind profile